August 31, 2016

Eos Capital is pleased to announce that it has acquired 35% of the ordinary share capital of Fabupharm (Pty) Ltd, pending Namibian Competition Commission approval, with the aim of supporting Fabupharm in its ambition to become a major player in the Namibian